| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arsenic | 25 | 2025 | 272 | 3.400 |
Why?
|
| DNA Methylation | 21 | 2025 | 697 | 2.440 |
Why?
|
| Transcriptome | 5 | 2025 | 762 | 1.880 |
Why?
|
| Telomere | 10 | 2025 | 120 | 1.620 |
Why?
|
| Polymorphism, Single Nucleotide | 30 | 2025 | 2484 | 1.460 |
Why?
|
| Colorectal Neoplasms | 6 | 2024 | 1053 | 1.450 |
Why?
|
| Genome-Wide Association Study | 22 | 2025 | 1762 | 1.360 |
Why?
|
| Skin Neoplasms | 5 | 2025 | 620 | 1.320 |
Why?
|
| Gene-Environment Interaction | 4 | 2025 | 120 | 1.140 |
Why?
|
| Environmental Exposure | 14 | 2025 | 355 | 1.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2025 | 1338 | 1.030 |
Why?
|
| Water Pollutants, Chemical | 11 | 2022 | 140 | 0.950 |
Why?
|
| Bangladesh | 31 | 2025 | 339 | 0.940 |
Why?
|
| Mutation | 4 | 2024 | 4272 | 0.870 |
Why?
|
| Telomere Shortening | 4 | 2021 | 25 | 0.860 |
Why?
|
| Genome, Human | 10 | 2019 | 823 | 0.850 |
Why?
|
| Sequence Deletion | 1 | 2025 | 209 | 0.830 |
Why?
|
| Carcinoma, Papillary | 2 | 2023 | 159 | 0.810 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2024 | 178 | 0.770 |
Why?
|
| Drinking Water | 6 | 2023 | 70 | 0.720 |
Why?
|
| DNA | 5 | 2023 | 1265 | 0.650 |
Why?
|
| Gene Expression Profiling | 8 | 2025 | 1518 | 0.650 |
Why?
|
| Thyroid Neoplasms | 2 | 2023 | 442 | 0.640 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 8 | 2017 | 691 | 0.630 |
Why?
|
| Arsenic Poisoning | 9 | 2023 | 104 | 0.610 |
Why?
|
| Middle Aged | 45 | 2025 | 27573 | 0.540 |
Why?
|
| Aging | 4 | 2025 | 727 | 0.530 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 61 | 0.530 |
Why?
|
| Genetic Predisposition to Disease | 15 | 2024 | 2465 | 0.510 |
Why?
|
| Humans | 77 | 2025 | 93515 | 0.490 |
Why?
|
| Male | 47 | 2025 | 44557 | 0.490 |
Why?
|
| Telomere Homeostasis | 4 | 2021 | 29 | 0.480 |
Why?
|
| Female | 53 | 2025 | 48702 | 0.470 |
Why?
|
| Epigenesis, Genetic | 7 | 2025 | 555 | 0.460 |
Why?
|
| CpG Islands | 10 | 2024 | 168 | 0.460 |
Why?
|
| Adult | 38 | 2025 | 27918 | 0.430 |
Why?
|
| Aged | 23 | 2025 | 20434 | 0.420 |
Why?
|
| Quantitative Trait Loci | 4 | 2022 | 630 | 0.410 |
Why?
|
| Microsatellite Instability | 2 | 2024 | 64 | 0.410 |
Why?
|
| Breast Neoplasms | 10 | 2018 | 3110 | 0.390 |
Why?
|
| Chromosome Aberrations | 2 | 2012 | 350 | 0.390 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2024 | 1229 | 0.380 |
Why?
|
| Skin Diseases | 5 | 2019 | 174 | 0.360 |
Why?
|
| Genotype | 9 | 2019 | 1866 | 0.340 |
Why?
|
| Smoking | 4 | 2024 | 648 | 0.340 |
Why?
|
| Cardiovascular Diseases | 4 | 2023 | 754 | 0.320 |
Why?
|
| Longitudinal Studies | 12 | 2023 | 1161 | 0.320 |
Why?
|
| Organ Specificity | 4 | 2025 | 279 | 0.310 |
Why?
|
| Methyltransferases | 5 | 2025 | 213 | 0.290 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2008 | 41 | 0.290 |
Why?
|
| Colon | 1 | 2012 | 540 | 0.280 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2020 | 590 | 0.280 |
Why?
|
| Precision Medicine | 1 | 2012 | 456 | 0.260 |
Why?
|
| Carotid Intima-Media Thickness | 2 | 2018 | 39 | 0.250 |
Why?
|
| Glutathione Transferase | 2 | 2025 | 115 | 0.240 |
Why?
|
| Oxygenases | 1 | 2025 | 17 | 0.230 |
Why?
|
| Air Pollutants | 2 | 2024 | 108 | 0.230 |
Why?
|
| Loss of Heterozygosity | 3 | 2012 | 84 | 0.230 |
Why?
|
| Body Mass Index | 4 | 2019 | 811 | 0.230 |
Why?
|
| Young Adult | 12 | 2023 | 6930 | 0.220 |
Why?
|
| Case-Control Studies | 11 | 2022 | 1931 | 0.220 |
Why?
|
| Biomarkers, Tumor | 4 | 2018 | 1660 | 0.210 |
Why?
|
| Arsenicals | 2 | 2023 | 49 | 0.210 |
Why?
|
| Metals | 1 | 2025 | 102 | 0.210 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2012 | 418 | 0.210 |
Why?
|
| Leukocytes | 3 | 2025 | 210 | 0.210 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2024 | 63 | 0.210 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2024 | 106 | 0.200 |
Why?
|
| Cigarette Smoking | 1 | 2024 | 47 | 0.200 |
Why?
|
| Incidence | 3 | 2022 | 1701 | 0.190 |
Why?
|
| Air Pollution | 1 | 2023 | 107 | 0.180 |
Why?
|
| Multifactorial Inheritance | 3 | 2024 | 202 | 0.180 |
Why?
|
| Liver Neoplasms | 3 | 2012 | 776 | 0.180 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2023 | 162 | 0.180 |
Why?
|
| Genetic Variation | 5 | 2022 | 1415 | 0.180 |
Why?
|
| Bacteria | 3 | 2020 | 509 | 0.170 |
Why?
|
| Tissue Fixation | 2 | 2012 | 39 | 0.170 |
Why?
|
| Feces | 2 | 2020 | 360 | 0.170 |
Why?
|
| Formaldehyde | 2 | 2012 | 51 | 0.170 |
Why?
|
| Paraffin Embedding | 2 | 2012 | 77 | 0.170 |
Why?
|
| Cacodylic Acid | 3 | 2021 | 22 | 0.170 |
Why?
|
| Reproducibility of Results | 4 | 2018 | 2715 | 0.170 |
Why?
|
| Gene Expression Regulation | 4 | 2018 | 1985 | 0.170 |
Why?
|
| Risk Factors | 10 | 2023 | 5899 | 0.160 |
Why?
|
| Phenotype | 6 | 2019 | 2544 | 0.160 |
Why?
|
| Selenomethionine | 2 | 2013 | 11 | 0.160 |
Why?
|
| Epigenomics | 2 | 2024 | 109 | 0.160 |
Why?
|
| Blood | 1 | 2019 | 68 | 0.150 |
Why?
|
| Disease Progression | 1 | 2024 | 1531 | 0.150 |
Why?
|
| Ammonia-Lyases | 1 | 2019 | 6 | 0.150 |
Why?
|
| Glutamate Formimidoyltransferase | 1 | 2019 | 6 | 0.150 |
Why?
|
| Anthropometry | 1 | 2019 | 75 | 0.150 |
Why?
|
| Receptors, Opioid | 1 | 2019 | 23 | 0.150 |
Why?
|
| Antioxidants | 2 | 2013 | 231 | 0.150 |
Why?
|
| Tobacco Smoking | 1 | 2019 | 31 | 0.140 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2018 | 42 | 0.140 |
Why?
|
| Cross-Sectional Studies | 6 | 2023 | 1847 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2023 | 47 | 0.140 |
Why?
|
| Smoking Cessation | 2 | 2019 | 269 | 0.140 |
Why?
|
| Alleles | 4 | 2019 | 1139 | 0.130 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2024 | 1077 | 0.130 |
Why?
|
| Agricultural Workers' Diseases | 1 | 2017 | 18 | 0.130 |
Why?
|
| Naltrexone | 1 | 2019 | 139 | 0.130 |
Why?
|
| Pesticides | 1 | 2017 | 30 | 0.130 |
Why?
|
| Chromosomes, Human | 1 | 2017 | 65 | 0.130 |
Why?
|
| Narcotic Antagonists | 1 | 2019 | 170 | 0.130 |
Why?
|
| DNA Helicases | 1 | 2017 | 89 | 0.130 |
Why?
|
| Cohort Studies | 6 | 2020 | 3054 | 0.130 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 71 | 0.120 |
Why?
|
| Algorithms | 1 | 2025 | 1953 | 0.120 |
Why?
|
| Prospective Studies | 7 | 2023 | 4560 | 0.120 |
Why?
|
| Gene Dosage | 3 | 2012 | 211 | 0.120 |
Why?
|
| Occupational Exposure | 1 | 2017 | 87 | 0.120 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2018 | 176 | 0.120 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 192 | 0.120 |
Why?
|
| Adolescent | 8 | 2024 | 9606 | 0.120 |
Why?
|
| Biomarkers | 4 | 2023 | 1910 | 0.120 |
Why?
|
| Mortality | 1 | 2017 | 156 | 0.120 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2016 | 129 | 0.120 |
Why?
|
| Parents | 1 | 2018 | 292 | 0.120 |
Why?
|
| Atherosclerosis | 1 | 2018 | 256 | 0.120 |
Why?
|
| Precancerous Conditions | 2 | 2007 | 205 | 0.120 |
Why?
|
| Water Wells | 3 | 2022 | 18 | 0.110 |
Why?
|
| Colonic Neoplasms | 1 | 2019 | 579 | 0.110 |
Why?
|
| Receptors, Progesterone | 1 | 2016 | 196 | 0.110 |
Why?
|
| Blotting, Southern | 1 | 2014 | 110 | 0.110 |
Why?
|
| Parity | 1 | 2015 | 97 | 0.110 |
Why?
|
| Water Pollution, Chemical | 2 | 2012 | 21 | 0.110 |
Why?
|
| Hypothyroidism | 1 | 2017 | 275 | 0.110 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2020 | 259 | 0.110 |
Why?
|
| Phosphofructokinase-1, Muscle Type | 1 | 2014 | 9 | 0.100 |
Why?
|
| Environmental Pollutants | 1 | 2014 | 56 | 0.100 |
Why?
|
| Receptors, Estrogen | 1 | 2016 | 413 | 0.100 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 381 | 0.100 |
Why?
|
| Water Supply | 1 | 2014 | 66 | 0.100 |
Why?
|
| Databases, Genetic | 2 | 2012 | 282 | 0.100 |
Why?
|
| alpha-Tocopherol | 1 | 2013 | 9 | 0.100 |
Why?
|
| Anticarcinogenic Agents | 1 | 2013 | 71 | 0.090 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2019 | 646 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 317 | 0.090 |
Why?
|
| Child | 4 | 2025 | 7355 | 0.090 |
Why?
|
| Frozen Sections | 1 | 2012 | 50 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2012 | 83 | 0.090 |
Why?
|
| Mosaicism | 1 | 2012 | 73 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2012 | 109 | 0.090 |
Why?
|
| Odds Ratio | 3 | 2019 | 711 | 0.090 |
Why?
|
| Blood Pressure | 1 | 2015 | 896 | 0.090 |
Why?
|
| Specimen Handling | 1 | 2012 | 109 | 0.090 |
Why?
|
| Chromosome Deletion | 1 | 2012 | 214 | 0.090 |
Why?
|
| Polymorphism, Genetic | 1 | 2015 | 826 | 0.080 |
Why?
|
| Genetic Loci | 1 | 2012 | 260 | 0.080 |
Why?
|
| Analysis of Variance | 2 | 2010 | 884 | 0.080 |
Why?
|
| DNA, Neoplasm | 1 | 2011 | 266 | 0.080 |
Why?
|
| Hypertension | 1 | 2015 | 757 | 0.080 |
Why?
|
| Placental Lactogen | 1 | 2008 | 12 | 0.070 |
Why?
|
| Chorionic Gonadotropin | 1 | 2008 | 69 | 0.070 |
Why?
|
| Linear Models | 2 | 2025 | 413 | 0.070 |
Why?
|
| Sex Factors | 1 | 2012 | 1105 | 0.070 |
Why?
|
| Neoplasms | 1 | 2023 | 3169 | 0.070 |
Why?
|
| Gene Amplification | 1 | 2008 | 140 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2012 | 580 | 0.070 |
Why?
|
| Genetic Markers | 2 | 2020 | 469 | 0.070 |
Why?
|
| Gene Expression | 2 | 2024 | 1301 | 0.060 |
Why?
|
| Placenta | 1 | 2008 | 189 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2008 | 756 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 3830 | 0.060 |
Why?
|
| Methylation | 2 | 2019 | 288 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2025 | 3829 | 0.060 |
Why?
|
| Mercury | 1 | 2025 | 11 | 0.060 |
Why?
|
| Nails | 1 | 2025 | 11 | 0.060 |
Why?
|
| Volatile Organic Compounds | 1 | 2024 | 4 | 0.060 |
Why?
|
| Silicones | 1 | 2024 | 21 | 0.060 |
Why?
|
| Wrist | 1 | 2024 | 29 | 0.050 |
Why?
|
| Multigene Family | 1 | 2025 | 203 | 0.050 |
Why?
|
| Environmental Monitoring | 1 | 2024 | 89 | 0.050 |
Why?
|
| Enteroendocrine Cells | 1 | 2024 | 8 | 0.050 |
Why?
|
| Chromosome Mapping | 2 | 2022 | 1052 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2006 | 454 | 0.050 |
Why?
|
| Resistin | 1 | 2023 | 12 | 0.050 |
Why?
|
| Ghrelin | 1 | 2023 | 27 | 0.050 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2015 | 58 | 0.050 |
Why?
|
| Troponin | 1 | 2023 | 26 | 0.050 |
Why?
|
| Microsatellite Repeats | 1 | 2024 | 150 | 0.050 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2015 | 76 | 0.050 |
Why?
|
| Diabetic Nephropathies | 1 | 2024 | 89 | 0.050 |
Why?
|
| Chromosomes, Human, Y | 1 | 2023 | 26 | 0.050 |
Why?
|
| C-Peptide | 1 | 2023 | 184 | 0.050 |
Why?
|
| Leptin | 1 | 2023 | 100 | 0.050 |
Why?
|
| Prevalence | 2 | 2017 | 1321 | 0.050 |
Why?
|
| Inflammation | 2 | 2024 | 1050 | 0.050 |
Why?
|
| Interleukin-17 | 1 | 2024 | 109 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2025 | 402 | 0.050 |
Why?
|
| Genomic Instability | 1 | 2023 | 88 | 0.050 |
Why?
|
| Adipocytes | 1 | 2024 | 169 | 0.050 |
Why?
|
| Peripheral Arterial Disease | 1 | 2024 | 101 | 0.050 |
Why?
|
| Age of Onset | 2 | 2017 | 342 | 0.050 |
Why?
|
| Particulate Matter | 1 | 2023 | 123 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2023 | 276 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 198 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2024 | 477 | 0.040 |
Why?
|
| Cluster Analysis | 2 | 2012 | 391 | 0.040 |
Why?
|
| Chromatin | 1 | 2024 | 440 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2024 | 557 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2023 | 688 | 0.040 |
Why?
|
| Waist-Hip Ratio | 1 | 2019 | 21 | 0.040 |
Why?
|
| Waist Circumference | 1 | 2019 | 24 | 0.040 |
Why?
|
| Multifunctional Enzymes | 1 | 2019 | 7 | 0.040 |
Why?
|
| Clostridiales | 1 | 2019 | 18 | 0.040 |
Why?
|
| Prognosis | 2 | 2018 | 3911 | 0.040 |
Why?
|
| Thinness | 1 | 2019 | 45 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2024 | 375 | 0.040 |
Why?
|
| Folic Acid | 1 | 2019 | 62 | 0.040 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2018 | 7 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2018 | 40 | 0.030 |
Why?
|
| Body Weight | 1 | 2019 | 449 | 0.030 |
Why?
|
| Iowa | 1 | 2017 | 33 | 0.030 |
Why?
|
| North Carolina | 1 | 2017 | 56 | 0.030 |
Why?
|
| Myosins | 1 | 2018 | 86 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2019 | 297 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 2018 | 90 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2020 | 960 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2019 | 333 | 0.030 |
Why?
|
| Longevity | 1 | 2017 | 60 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2019 | 700 | 0.030 |
Why?
|
| Pregnancy | 2 | 2018 | 3147 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 179 | 0.030 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2016 | 50 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2017 | 277 | 0.030 |
Why?
|
| Menopause | 1 | 2016 | 87 | 0.030 |
Why?
|
| Thyrotropin | 1 | 2017 | 309 | 0.030 |
Why?
|
| Chicago | 1 | 2020 | 1464 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2017 | 579 | 0.030 |
Why?
|
| Triiodothyronine | 1 | 2017 | 361 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 296 | 0.030 |
Why?
|
| Thyroxine | 1 | 2017 | 386 | 0.030 |
Why?
|
| Vitamin E | 1 | 2014 | 34 | 0.030 |
Why?
|
| Asia | 1 | 2014 | 107 | 0.030 |
Why?
|
| Selenium | 1 | 2014 | 46 | 0.030 |
Why?
|
| Biological Assay | 1 | 2014 | 82 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2018 | 443 | 0.030 |
Why?
|
| Chemoprevention | 1 | 2014 | 93 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 1243 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 1524 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2016 | 585 | 0.020 |
Why?
|
| E-Selectin | 1 | 2012 | 31 | 0.020 |
Why?
|
| Peroxidase | 1 | 2012 | 54 | 0.020 |
Why?
|
| Genes, Homeobox | 1 | 2012 | 84 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2018 | 1234 | 0.020 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2012 | 46 | 0.020 |
Why?
|
| Genomics | 1 | 2018 | 848 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2012 | 83 | 0.020 |
Why?
|
| Survival Rate | 1 | 2016 | 1948 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2010 | 39 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2014 | 1118 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2010 | 167 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2012 | 436 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2018 | 1691 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 524 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2013 | 1729 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2008 | 42 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2008 | 78 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2008 | 85 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2010 | 730 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2008 | 102 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2015 | 2441 | 0.020 |
Why?
|
| Methylenetetrahydrofolate Dehydrogenase (NADP) | 1 | 2007 | 4 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 7061 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 5410 | 0.020 |
Why?
|
| Population Groups | 1 | 2006 | 42 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 2007 | 139 | 0.010 |
Why?
|
| Haplotypes | 1 | 2008 | 647 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2007 | 208 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 9099 | 0.010 |
Why?
|
| Stroke | 1 | 2015 | 1079 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2008 | 917 | 0.010 |
Why?
|
| RNA | 1 | 2007 | 573 | 0.010 |
Why?
|
| Animals | 1 | 2018 | 28155 | 0.010 |
Why?
|